Business Context and Reporting Period
This Form 6-K filing by Golden Sun Health Technology Group Limited covers the month of September 2025. The report discloses a material change in executive leadership, specifically the resignation of the Chief Operating Officer (COO) and the subsequent appointment of a successor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and executive compensation rather than financial performance.
Material Changes
- Resignation: Ms. Xiaoyi Wang resigned as COO effective September 18, 2025, citing personal reasons. The resignation was not due to any dispute with the Company or its board.
- Appointment: Mr. Duo Ye was appointed as COO effective September 18, 2025, to fill the vacancy.
- Compensation: Mr. Ye's employment agreement, dated September 24, 2025, stipulates a monthly salary of $3,233 plus standard employee benefits.
Outlook, Risks, and Management Commentary
Management Background: Mr. Ye brings over a decade of senior management experience in financial services and media. His recent roles include General Manager at Zhejiang Jintaiyang Selection Technology Co., Ltd. (2023–2025) and COO at Jinhua Single Dog Culture Media Co., Ltd. (2020–2023).
Employment Terms: The agreement is for a three-year term (September 18, 2025, to September 17, 2028), subject to automatic renewal unless terminated with two months' notice. The Company retains the right to terminate for cause without notice or remuneration for serious breaches, criminal offenses, fraud, or severe neglect of duties.
Risks and Contingencies: The filing states there are no family relationships between Mr. Ye and other directors or officers, and no reportable related-party transactions exist under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the full text of the Employment Agreement (Exhibit 10.1) for complete terms and conditions.
- Confirm the strategic fit of Mr. Ye's background in financial services and media with the Company's core health technology operations.
- Monitor future filings for any financial impact resulting from the leadership transition.